库尔库明通过调节癌症相关纤维细胞衍生的外体miRNA-146aa调节树突细胞成熟
Sheefa Mirza1,2,3, Clement Penny1, Nayan K Jain2
1Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Journal of cancer research and therapeutics
|February 22, 2024
概括
与癌症相关的纤维细胞 (CAFs) 产生调节性树突细胞 (DCs),抑制免疫反应. 黄可以扭转这种情况,促进成熟的DC,并通过调节瘤微环境 (TME) 来增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 癌症相关纤维细胞 (CAF) 是瘤微环境 (TME) 的关键组成部分,通过分泌因素影响免疫反应.
- 对CAFs对树突细胞 (DC) 成熟和功能的具体影响仍然不完全理解.
研究的目的:
- 研究肺CAF衍生的外体和细胞因子对DC成熟的作用.
- 评估黄素在TME内调节DC成熟的免疫调节潜力.
主要方法:
- 未成熟的DCs (imDCs) 用CAFs-条件介质 (CAFs-CM) 进行培养,通过qRT-PCR评估DC成熟标志物 (CD80,CD83,CD86,CTLA4).
- 使用ELISA分析了CAF-CM中的表观遗传调节剂 (miRNAs:miR-221,miR-222,miR-155,miR-142-3p,miR-146a) 和细胞因子.
- 还评估了黄素对CAFs-CM治疗的DCs的影响.
主要成果:
- CAFs-CM诱导的调节性DCs具有降低的成熟标志物和增加的miR-146a表达.
- 这些调节性DCs表现出高的抗炎细胞因子 (IL-6,IL-10,TGF-β) 和降低TNF-α.
- 黄素治疗使调节性DC转向成熟的DC (mDC),增强了共刺激分子和降低了免疫抑制因素和miR-146a.
结论:
- 肺CAFs通过特定的miRNA和细胞因子促进DC不成熟和免疫抑制.
- 黄素有效地逆转CAF介导的DC抑制,促进抗瘤免疫力.
- 这些发现突显了黄素在基于DC的癌症免疫疗法中的潜力,通过向CAF和TME.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


